[1]
Hagman, H. et al. 2017. Vasoactive peptides associate with treatment outcome ofbevacizumab-containing therapy in metastatic colorectal cancer. Acta Oncologica. 56, 5 (Jun. 2017), 653–660. DOI:https://doi.org/10.1080/0284186X.2017.1302098.